Head of department, Safety Pharmacology and Exploratory Toxicology

Novo Nordisk

Since graduation from the Royal Veterinary and Agricultural University in Copenhagen, Denmark in 1996, Tomas Mow has worked in cardiovascular sciences and safety pharmacology. In 1999 Tomas completed his PhD in cardiac diseases in pet dogs. The same year he was employed at H. Lundbeck Department of Safety Pharmacology, initially as research scientist and later as Head of Department. From 2008 to 2015 Tomas headed the Department of Exploratory Toxicology establishing the strategy for frontloading of safety pharmacology and toxicology assays in the drug discovery process at H. Lundbeck.

Since 2016 Tomas heads the Department of Safety Pharmacology and Exploratory Toxicology at Novo Nordisk. Tomas is co-author on a number of publications in the area of Safety Pharmacology and Exploratory Toxicology. In addition, he is currently a member of the Board of Directors in the Safety Pharmacology Society (SPS).